Leiden Bio Science Park recently welcomed a high-level delegation from the European Commission during a visit to Johnson & Johnson, organised by Amoy Anderson, and the team.
The visit centred on the impact of international trade on the Life Sciences and Health sectors, both in the Netherlands and the wider EU. The morning began with a welcome by Wietske Veltman, Alderman for Economy, Knowledge, Health, and Sports for the Municipality of Leiden, followed by a presentation from Esther Peters, Director of Leiden Bio Science Park.
Key speakers included Anneke Sanders (Bristol Myers Squibb), Jan de Sonneville (Life Science Methods), Anouk De Vroey (Johnson & Johnson), and Professor Thomas Hankemeier (Leiden University), who emphasised the Park’s strong academic and translational capabilities.
In the afternoon, Rob van Overbeek from Kadans Science Partner led a tour introducing the delegation to three innovative companies: LeydenJar (battery innovation), Meatable (sustainable food production), and VarmX (therapies for bleeding disorders).
The visit highlighted the Park’s role in fostering innovation and international collaboration, reinforcing its mission to support science that serves society.
We recently hosted Tjerk Opmeer from the Ministry of Economic Affairs at Leiden Bio Science Park to share insights into building a shared investment agenda for Dutch biotech....
A new collaboration between TNO, Proefdiervrij, and pharmaceutical company Galapagos, called MechPath, is accelerating the transition to animal-free drug development. By...
The first Works Council Community meeting at Leiden Bio Science Park tackled workplace conduct and culture through honest, practical dialogue. With HR and legal experts in the room, the session marked the start of a collaborative effort to foster safer, more respectful workplaces.